Susan Leigh
About
In The Last Decade
Susan Leigh
26 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 106
- Oncology 971
- Pediatrics, Perinatology and Child Health 557
- Sociology and Political Science 364
- Pulmonary and Respiratory Medicine 294
- Public Health, Environmental and Occupational Health 243
Countries citing papers authored by Susan Leigh
This map shows the geographic impact of Susan Leigh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Leigh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Leigh more than expected).
Fields of papers citing papers by Susan Leigh
This network shows the impact of papers produced by Susan Leigh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Leigh. The network helps show where Susan Leigh may publish in the future.
Co-authorship network of co-authors of Susan Leigh
This figure shows the co-authorship network connecting the top 25 collaborators of Susan Leigh. A scholar is included among the top collaborators of Susan Leigh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Leigh. Susan Leigh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 10 | |
| 3 | 2 | |
| 4 | 5 | |
| 5 | 9 | |
| 6 | 1 | |
| 7 | 9 | |
| 8 | 276 | |
| 9 | 280 | |
| 10 | Cancer survivorship: a consumer movement. | 14 |
| 11 | 2 | |
| 12 | 20 | |
| 13 | 77 | |
| 14 | Disposition of mitoxantrone in cancer patients. | 72 |
| 15 | 33 | |
| 16 | Pharmacokinetics of 13-cis-retinoic acid in patients with advanced cancer. | 40 |
| 17 | Improved survival for relapsing ovarian cancer (OVCA) patients using the human tumor stem cell assay (HTSCA) to select chemotherapy (CRx) | 17 |
| 18 | Nabilone: a potent antiemetic cannabinol with minimal euphoria. | 32 |
| 19 | 15 | |
| 20 | 100 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.